Acta medica Indonesiana
-
Acta medica Indonesiana · Apr 2011
Randomized Controlled TrialSafety and feasibility of combined granulocyte colony stimulating factor and erythropoetin based-stem cell therapy using intracoronary infusion of peripheral blood stem cells in patients with recent anterior myocardial infarction: one-year follow-up of a phase 1 study.
to assess the safety and feasibility of combined granulocyte colony-stimulating factor (G-CSF) and erythropoietin (EPO) based intracoronary peripheral blood stem cells (PBSCs) therapy in patients with recent myocardial infarction (RMI) who had successful reperfusion therapy with drug-eluting stent. ⋯ combined G-CSF and EPO based- intracoronary infusion of PBSCs in patients RAMI is safe and feasible.